Targeted Therapeutic Delivery and Personalized Medicine System

A next-generation liposome-based system for targeted delivery of therapeutic molecules to diseased tissues, integrating pH-sensitive liposomes, nanoparticle-based targeting agents, and wearable devices for personalized medicine.

Despite advances in cancer diagnosis and treatment, existing methods for delivering therapeutic molecules to diseased tissues are limited by their lack of specificity, inefficiency, and inability to adapt to individual patients' needs. The original patent's liposome compositions and methods, while effective, are restricted to specific pH environments and lack the ability to monitor and respond to patients' physiological conditions.

The new inventive concept comprises a pH-sensitive liposome capable of releasing cargo in response to acidic microenvironments, a nanoparticle-based targeting agent that selectively binds to diseased tissue cells, and a wearable device that monitors the patient's physiological conditions and adjusts the liposome's release profile accordingly. This integrated system enables targeted delivery of therapeutic molecules, including RNA-based vaccines and CRISPR-Cas9 complexes, to specific cells or tissues, while allowing for real-time monitoring and adaptation to individual patients' needs.

The new inventive concept's integration of pH-sensitive liposomes, nanoparticle-based targeting agents, and wearable devices for personalized medicine represents a significant departure from the original patent's limitations, providing a more ambitious and forward-thinking approach to targeted therapeutic delivery.

Alternative embodiments of the inventive concept could include the use of different types of nanoparticles, liposome compositions, or wearable devices, as well as the integration of additional components, such as sensors or microfluidics, to further enhance the system's functionality and adaptability.

The inventive concept has significant commercial potential in the fields of cancer treatment, gene editing, and personalized medicine, with potential applications in the development of targeted therapies, vaccines, and diagnostic tools.